911±¬ÁÏÍø

Drugs with the potential to change the course of Alzheimer’s disease are expected to be approved by mid-year in the UK, but the NHS may struggle to ensure equitable access, suggests research led by Professor Rimona Weil, (UCL Queen Square Institute of Neurology).

;Ìý,Ìý,Ìý,Ìý,Ìý,Ìý,Ìý,Ìý911±¬ÁÏÍøews